MELTON AFFRIME, PHARM.D.
Senior Vice President, Global Clinical Pharmacology
As Senior Vice President of the Development Solutions Division,
Dr. Affrime is responsible, globally, for ICON's clinical pharmacology
activities.
Dr. Affrime has 23 years of demonstrated success in Global Pharmaceutical
Development. Dr. Affrime received his Pharm.D. from The Philadelphia
College of Pharmacy and Science in 1976. He did a joint Residency in
Hospital Pharmacy and Fellowship in Clinical Pharmacology with Marcus
Reidenberg, MD at Temple University Medical College and Hospital from
1972 to 1974. He was appointed Senior Instructor of Pharmacology and Medicine
at Hahnemann Medical College in 1976.
In 1977 he was Appointed Assistant Professor Pharmacology and Medicine
and Co-Founded the Hahnemann Clinical Pharmacology Research Unit
with David Lowenthal, MD. Dr. Affrime joined Hoechst-Roussel Pharmaceuticals as
Associate Director of Clinical Research, Clinical Pharmacology in 1982 and in 1985
became Director Clinical Pharmacology at Schering-Plough Research Institute.
From 1985 to 2002 he held positions of increasing responsibility and was appointed
Vice President of Clinical Research, Clinical Pharmacology in 1994. From 1994 to 2002
he increased his scope of responsibilities at Schering-Plough to include Clinical Research
Training and GCP Compliance. Melton was appointed Global Head, Profiling Clinical
Pharmacology at Novartis Pharmaceuticals in 2002.
